Glucagon Storage: A Descriptive Summary of Key Locations
Glucagon Storage: A Descriptive Summary of Key Locations Glucagon, a 29-amino acid peptide hormone, is primarily stored in the alpha cells of the pancreatic islets. Within these cells, it is packaged into secretory granules, ready for exocytosis in response to hypoglycemia. Minor extrapancreatic storage occurs in intestinal L-cells and the brain. In the pharmaceutical market, synthetic glucagon (e.g., GlucaGen, Baqsimi) dominates, offering stability advantages over animal-derived forms. Current industry trends show a shift toward room-temperature stable, non-injectable formulations (nasal powder, dual-chamber pens), driven by diabetes management demand. Key product parameters include purity (>98% by HPLC) and bioactivity (≥20 IU/mg). Leading brands like Novo Nordisk and Eli Lilly prioritize GMP-certified facilities, ensuring regulatory compliance. For buyers, verifying third-party certificates of analysis (CoA) and cold-chain logistics (2–8°C for liquid forms) is critical. The global glucagon market is projected to grow at 8.2% CAGR through 2030, fueled by emergency care and obesity research.